Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) remains a significant source of mortality in critically ill patients. Characterised by acute, widespread alveolar inflammation and pulmonary oedema, its pathophysiological heterogeneity has meant that targeted treatments have remained elusive. Metabolomic a...
| Автори: | , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
European Respiratory Society
2020-07-01
|
| Серія: | European Respiratory Review |
| Онлайн доступ: | http://err.ersjournals.com/content/29/156/200114.full |